i2o Therapeutics: Harvard-launched biotech startup i2O Therapeutics launches to replace syringes with pills for oral delivery of many injectable drugs, including insulin

i2o Therapeutics, a Boston, MA-based biotech startup developing a platform for oral delivery of traditionally injectable biological drugs, has launched to commercialize innovations developed at Harvard University that may one day enable patients and clinicians to give up syringes in [...]The post Harvard-launched biotech startup i2O Therapeutics launches to replace syringes with pills for oral delivery of many injectable drugs, including insulin appeared first on Tech News | Startups News.